Erez Aminov is the Chairman and Chief Executive Officer of MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a pre-clinical-stage biopharmaceutical company at the forefront of developing innovative treatments for neuropsychiatric disorders. Under his leadership, MIRA is advancing transformative therapies such as MIRA55 and Ketamir-2, aiming to address critical unmet medical needs with safe and effective solutions.

With a deep expertise in biotechnology consulting, investment, and leadership, Mr. Aminov has played a pivotal role in shaping the biopharma landscape. Prior to joining MIRA, he founded Locate Venture Corp, where he supported early-stage biotech enterprises and fostered growth through strategic partnerships. He has also served as a trusted consultant for multiple biotech firms and successfully guided two companies through IPOs on the Nasdaq, showcasing his ability to navigate complex financial and regulatory environments.

At MIRA, Mr. Aminov has been instrumental in securing funding, licensing proprietary technologies, and overseeing the submission of Investigational New Drug (IND) applications. His strategic vision continues to position MIRA for success, with pivotal preclinical studies paving the way for clinical advancements.

In addition, Mr. Aminov serves as the Chairman and Chief Executive Officer of Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), a biotechnology company dedicated to developing Telomir-1, an innovative therapeutic targeting telomere elongation and protection to treat age- related inflammatory and degenerative conditions.

Mr. Aminov holds a Bachelor of Arts in Accounting from Touro University in New York. His unique blend of financial acumen and forward-thinking leadership drives his mission to advance groundbreaking therapies and deliver value to stakeholders.

Dr. Matthew P. Del Giudice has practiced as a radiologist since 2014. He is a general overnight emergency radiologist at the Cleveland Clinic and a real estate investor with Comfort Living, LLC. Before joining the Cleveland Clinic, from March 2021 to May 2022, Dr. Del Giudice was a general radiologist with Radiology and Imaging Specialists in Phoenix, Arizona. From July 2015 to February 2021, Dr. Del Giudice was a radiologist with Radiology Partners Phoenix, and from July 2014 to June 2015, he practiced as a musculoskeletal radiologist at the University of Arizona Health Sciences Center – Tucson. Dr. Del Giudice received his B.S. from the University of Illinois at Urbana-Champaign, his M.D. from Loyola University Stritch School of Medicine, completed his radiology residency at Loyola University Medical Center, and his musculoskeletal radiology fellowship at the University of Arizona Health Sciences Center – Tucson. Dr. Del Giudice is licensed to practice medicine in Florida and Ohio. Dr. Del Guidice has also served as a director of Telomir Pharmaceuticals, Inc. (Nasdaq: TELO).

Ned MacPherson currently serves as Chief Growth Officer for Power Digital, an industry-leading digital marketing agency. Before joining Power Digital, from May 2016 to December 2023, he served as CEO and Head of Growth for Endrock Growth & Analytics, a company he founded and sold to Power Digital. Prior to founding Endrock Growth & Analytics, Mr. MacPherson held senior marketing and leadership positions at sunglass maker Prive Revaux (March 2018 to April 2020), curated meal company Menud (October 2014 to April 2018) and Rejuvenetics, LLC, a distributor of health and wellness products (December 2012 to March 2016). Mr. Macpherson holds a BA in Economics from Gettysburg College. Mr. MacPherson has also served as a director of Telomir Pharmaceuticals, Inc. (Nasdaq: TELO).

Dr. Denil N. Shekhat has been a radiologist since 2014 and currently practices at DNS Teleradiology in Wellington, Florida. Before starting DNS Teleradiology, Dr. Shekhat was a musculoskeletal specialist for Radiology Associates of Florida/ Radiology Partners from July 2018 to December 2023. From July 2015 to August 2018, Dr. Shekhat practiced as a general and musculoskeletal radiologist with Bethesda Radiology Associates. Dr. Shekhat received his B.A. in economics from Bowdoin College, his M.D. from the University of Tennessee Health Science Center, College of Medicine, completed his radiology residency at Baptist Memorial Hospital and his musculoskeletal radiology fellowship at the University of Arizona. Dr. Shekhat is currently licensed to practice medicine in Florida.

Matthew Pratt Whalen, CPA, age 45, is a Certified Public Accountant with over two decades of experience in public accounting and corporate finance. Mr. Whalen currently serves as the Chief Financial Officer of Power Digital Marketing Inc., an industry leading digital marketing agency, where he has driven significant revenue growth and led key financial transactions. Specifically, Mr. Whalen oversees the finance team, manages tax and audit relationships, and handles treasury management. Prior to joining Power Digital, from 2010 to May 2021, Mr. Whalen was the Chief Financial Officer of MRC Smart Technology Solutions, a subsidiary of Xerox Corporation where he played a pivotal role in growing the company’s revenue and managed diverse teams across multiple departments. Mr. Whalen holds a B.A. in Accounting from the University of San Diego and is a Certified Public Accountant in California. Mr. Whalen has also served on the Finance Committee of United Way San Diego. We believe that Mr. Whalen is qualified to serve as one of our directors based on his extensive experience in finance and as a Certified Public Accountant. Mr. Whalen has also served as a director of Telomir Pharmaceuticals, Inc. (Nasdaq: TELO).